Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

GERON CORPORATION (GERN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2018 04/16/2018 04/17/2018 04/18/2018 04/19/2018 Date
3.85(c) 3.79(c) 3.99(c) 3.74(c) 3.71 Last
14 109 478 6 080 138 9 901 988 4 815 975 2 401 687 Volume
-3.51% -1.56% +5.28% -6.27% -0.80% Change
More quotes
Financials (USD)
Sales 2018 33,8 M
EBIT 2018 0,04 M
Net income 2018 0,09 M
Finance 2018 0,11 M
Yield 2018 -
Sales 2019 7,50 M
EBIT 2019 -31,9 M
Net income 2019 -31,2 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 748,00
P/E ratio 2019
Capi. / Sales2018 17,6x
Capi. / Sales2019 79,4x
Capitalization 596 M
More Financials
Company
Geron Corp. operates as a biotechnology company.It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.  
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : - Investor Rating :
More Ratings
Latest news on GERON CORPORATION
04/17Geron 2018 Annual Meeting of Stockholders to be Held on May 15
GL
04/13GERON CORPORATION : Today’s Research Reports on Stocks to Watch: Geron Corp. and..
AC
04/12THURSDAY SECTOR LEADERS : Biotechnology, Railroads
AQ
04/12GERON CORPORATION : Pomerantz Law Firm Investigates Claims On Behalf of Investo..
AC
04/05GERON CORPORATION : GERON Faruqi & Faruqi, LLP Encourages Investors Who Suffered..
AC
04/04GLANCY PRONGAY & MURRAY LLP : Announces Investigation on Behalf of Geron Corpora..
BU
04/03Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possib..
BU
04/02GERON : Why Geron Corporation Stock Is Falling Today
AQ
04/02Are Short-Sellers Right About Geron Corporation?
AQ
03/29GERON CORPORATION : The Schall Law Firm Announces it is Investigating Claims Aga..
AC
More news
Sector news : Bio Therapeutic Drugs
11:42aNew Novartis CEO feels heat on U.S. generics business
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Bio Therapeutic Drugs
Latest Tweets
04/18$NSPX .02?! CANCER PATENT GRANTED, 9 MIL O\S! $NVCN $SPY $GDX $FB $RNVA $BAC .. 
04/18Marten Co - Investment Companies Roundup - April 2018: British & American.. 
04/18Geron $GERN Shares Gap Up to $3.79  
04/17$NSPX .02?! CANCER PATENT GRANTED, 9 MIL O\S! $NVCN $SPY $GDX $FB $RNVA $BAC .. 
04/17Geron 2018 Annual Meeting of Stockholders to be Held on May 15  
More tweets
Qtime:65
News from SeekingAlpha
04/17The Logical Argument For Geron 
04/17Geron Faces A Make-Or-Break Catalyst This Week 
04/17PREMARKET GAINERS AS OF 9 : 05 am (04/17/2018) 
04/16Why Geron Doesn't Pass Our Screens 
04/15THE NO BS REPORT, WEEK 9 : Mostly Holding 
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 5,50 $
Spread / Average Target 47%
EPS Revisions
Managers
NameTitle
John A. Scarlett President, Chief Executive Officer & Director
Ho Young Huh Chairman
Olivia K. Bloom Chief Financial Officer, Treasurer & Executive VP
Karin Eastham Director
Robert Jay Spiegel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
GERON CORPORATION121.67%596
GILEAD SCIENCES5.35%98 675
VERTEX PHARMACEUTICALS10.10%41 476
REGENERON PHARMACEUTICALS-14.51%34 613
GENMAB15.65%12 876
BEIGENE LTD (ADR)73.08%9 059